Clinical trial
Efficacy and Safety of Favipiravir in Management of COVID-19
NCT04349241 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Favipiravir in Management of COVID-19
- Lead sponsor
- Ain Shams University
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 18, 2020
- Completion date
- June 20, 2020
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronavirus disease (covid-19)